Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. - Piccart-Gebhart,M.J.; Procter,M.; Leyland-Jones,B.; Goldhirsch,A.; Untch,M.; Smith,I.; Gianni,L.; Baselga,J.; Bell,R.; Jackisch,C.; Cameron,D.; Dowsett,M.; et al. (N Engl J Med, 2005)